Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

AIMS: SARS–CoV-2 causes severe respiratory syndrome (COVID-19) with high mortality due to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein discussing a possible novel therapeutic tool for COVID-19. METHODS: Virus binds to the cell surface receptor ACE2; indeed, recen...

Full description

Saved in:
Bibliographic Details
Published in:Acta Diabetol
Main Authors: Solerte, Sebastiano Bruno, Di Sabatino, Antonio, Galli, Massimo, Fiorina, Paolo
Format: Artigo
Language:Inglês
Published: Springer Milan 2020
Subjects:
Perspectives
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7275134/
https://ncbi.nlm.nih.gov/pubmed/32506195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-020-01539-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items